These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10880691)

  • 1. Precipitated and spontaneous withdrawal following administration of lorazepam but not zolpidem.
    Elliot EE; White JM
    Pharmacol Biochem Behav; 2000 Jun; 66(2):361-9. PubMed ID: 10880691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The acute effects of zolpidem compared to diazepam and lorazepam using radiotelemetry.
    Elliot EE; White JM
    Neuropharmacology; 2001 Apr; 40(5):717-21. PubMed ID: 11311900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term abecarnil administration produces tolerance and withdrawal signs in the rat.
    Elliot EE; White JM
    Eur J Pharmacol; 2000 Apr; 394(2-3):237-45. PubMed ID: 10771289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous flumazenil following acute and repeated exposure to lorazepam in healthy volunteers: antagonism and precipitated withdrawal.
    Griffiths RR; Evans SM; Guarino JJ; Roache JD; Furman WR; Liebson I; Schwam EM
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1163-74. PubMed ID: 8510001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zolpidem physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons.
    Weerts EM; Ator NA; Grech DM; Griffiths RR
    J Pharmacol Exp Ther; 1998 Apr; 285(1):41-53. PubMed ID: 9535993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [High-dose zolpidem dependence].
    Hoch HJ; Gehring C
    MMW Fortschr Med; 2013 May; 155(8):66-7. PubMed ID: 24437143
    [No Abstract]   [Full Text] [Related]  

  • 7. Precipitated and spontaneous withdrawal in baboons after chronic dosing with lorazepam and CGS 9896.
    Lamb RJ; Griffiths RR
    Drug Alcohol Depend; 1984 Sep; 14(1):11-7. PubMed ID: 6435982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zolpidem self-injection with concurrent physical dependence under conditions of long-term continuous availability in baboons.
    Weerts EM; Griffiths RR
    Behav Pharmacol; 1998 May; 9(3):285-97. PubMed ID: 9832941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance and withdrawal after chronic lorazepam treatment in rats.
    van der Laan JW; Jansen van't Land C; de Groot G
    Eur Neuropsychopharmacol; 1993 Dec; 3(4):521-31. PubMed ID: 8111226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous flumazenil following prolonged exposure to lormetazepam in humans: lack of precipitated withdrawal.
    Gerra G; Giucasto G; Zaimovic A; Fertonani G; Chittolini B; Avanzini P; Caccavari R; Delsignore R
    Int Clin Psychopharmacol; 1996 Jun; 11(2):81-8. PubMed ID: 8803645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic vs. central administration of common hypnotics reveals opposing effects on genioglossus muscle activity in rats.
    Park E; Younes M; Liu H; Liu X; Horner RL
    Sleep; 2008 Mar; 31(3):355-65. PubMed ID: 18363312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of calcium channel blockers on withdrawal syndrome of lorazepam in rats.
    Gupta MB; Nath C; Patnaik GK; Saxena RC
    Indian J Med Res; 1996 Jun; 103():310-4. PubMed ID: 8707372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zolpidem behavioral pharmacology in baboons: self-injection, discrimination, tolerance and withdrawal.
    Griffiths RR; Sannerud CA; Ator NA; Brady JV
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1199-208. PubMed ID: 1312162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem.
    Perrault G; Morel E; Sanger DJ; Zivkovic B
    J Pharmacol Exp Ther; 1992 Oct; 263(1):298-303. PubMed ID: 1403792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of inhibitory effect of diphenhydramine on benzodiazepine dependence in rats.
    Nath C; Patnaik GK; Saxena RC; Gupta MB
    Indian J Physiol Pharmacol; 1997 Jan; 41(1):42-6. PubMed ID: 10225031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA/alpha1-preferring antagonist beta-CCt in squirrel monkeys.
    Platt DM; Rowlett JK; Spealman RD; Cook J; Ma C
    Psychopharmacology (Berl); 2002 Nov; 164(2):151-9. PubMed ID: 12404077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective, randomized, trial of phenobarbital versus benzodiazepines for acute alcohol withdrawal.
    Hendey GW; Dery RA; Barnes RL; Snowden B; Mentler P
    Am J Emerg Med; 2011 May; 29(4):382-5. PubMed ID: 20825805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of central histaminergic system in lorazepam withdrawal syndrome in rats.
    Nath C; Gupta MB
    Pharmacol Biochem Behav; 2001 Apr; 68(4):777-82. PubMed ID: 11526976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent clozapine and lorazepam withdrawal psychosis with catatonia.
    Wang BZ; Gupta A; Bastiampillai T; Sani F
    Aust N Z J Psychiatry; 2012 Aug; 46(8):795-6. PubMed ID: 22495953
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of dopamine agonists and antagonists on the lorazepam withdrawal syndrome in rats.
    Nath C; Saxena RC; Gupta MB
    Clin Exp Pharmacol Physiol; 2000 Mar; 27(3):167-71. PubMed ID: 10744342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.